• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡非尼酮通过减少大鼠模型肾间质纤维化对慢性肾移植功能障碍的肾保护作用。

Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model.

机构信息

Department of Physical Education, Minjiang University, Fuzhou 350108, PR China.

Department of Urology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine (The People's Hospital of Fujian Province), Fuzhou 350004, PR China.

出版信息

Life Sci. 2019 Sep 15;233:116666. doi: 10.1016/j.lfs.2019.116666. Epub 2019 Jul 17.

DOI:10.1016/j.lfs.2019.116666
PMID:31325427
Abstract

AIM

Pirfenidone (PFD) has been used as medication for idiopathic pulmonary fibrosis due to its ability in reducing lung fibrosis. However, the underlying mode of action in renal fibrosis during chronic renal allograft dysfunction (CRAD) requires further investigation. Therefore, the present study was conducted to explore the effects of PFD on renal injury induced by CRAD.

MAIN METHODS

Initially, the CRAD rat model was established, followed by the intragastric administration of PFD to the rats. Urine and blood samples were collected and tested against indicators of renal functions. The renal tissues were microscopically observed to determine the changes in pathological morphology. The anti-inflammatory, anti-fibrotic and anti-oxidant properties of PFD were explored in the setting of CRAD.

KEY FINDINGS

The success rate of model establishment was 92.31%, which was reflected by weight loss, appetite loss, faded fur, and retarded reaction, with the symptoms found to exacerbate with time. PFD treatment could improve renal function, ameliorate inflammation and renal fibrosis as well as promote the anti-oxidant ability of renal allograft, indicating its potential role as an effective therapeutic agent for CRAD.

SIGNIFICANCE

In conclusion, PFD was found to have renoprotective effects on renal injury induced by CRAD, which resulted in the alleviation of inflammation and renal fibrosis, providing novelty for CRAD clinical treatment.

摘要

目的

吡非尼酮(PFD)因其能够减少肺纤维化而被用于治疗特发性肺纤维化。然而,慢性肾移植功能障碍(CRAD)期间肾纤维化的潜在作用机制仍需进一步研究。因此,本研究旨在探讨 PFD 对 CRAD 诱导的肾损伤的影响。

主要方法

首先建立 CRAD 大鼠模型,然后对大鼠进行 PFD 灌胃。收集尿液和血液样本,检测肾功能指标。观察肾组织的病理形态变化。探讨 PFD 在 CRAD 中的抗炎、抗纤维化和抗氧化作用。

主要发现

模型建立的成功率为 92.31%,表现为体重减轻、食欲减退、毛发褪色和反应迟钝,且症状随时间恶化。PFD 治疗可改善肾功能,减轻炎症和肾纤维化,促进肾移植的抗氧化能力,表明其在治疗 CRAD 方面具有潜在的有效性。

意义

综上所述,PFD 对 CRAD 诱导的肾损伤具有肾保护作用,可减轻炎症和肾纤维化,为 CRAD 的临床治疗提供了新的思路。

相似文献

1
Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model.吡非尼酮通过减少大鼠模型肾间质纤维化对慢性肾移植功能障碍的肾保护作用。
Life Sci. 2019 Sep 15;233:116666. doi: 10.1016/j.lfs.2019.116666. Epub 2019 Jul 17.
2
Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: through anti-fibrotic and anti-oxidative stress pathways.吡非尼酮在高血压诱导的肾损伤中的肾脏保护机制:通过抗纤维化和抗氧化应激途径。
Biomed Res. 2013;34(6):309-19. doi: 10.2220/biomedres.34.309.
3
Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.罗格列酮对大鼠慢性肾移植功能障碍的保护作用。
Transpl Immunol. 2019 Jun;54:20-28. doi: 10.1016/j.trim.2019.01.002. Epub 2019 Jan 22.
4
Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction.Sirt1在慢性肾移植功能障碍早期肾移植中的表达及意义
Transpl Immunol. 2018 Jun;48:18-25. doi: 10.1016/j.trim.2018.02.006. Epub 2018 Feb 13.
5
Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation.吡非尼酮和依维莫司对实验性肺移植后慢性移植物排斥反应发展的保护作用。
Histol Histopathol. 2016 Jul;31(7):793-805. doi: 10.14670/HH-11-712. Epub 2015 Dec 28.
6
The association between activation of the ERK1/2-NF-κB signaling pathway by TIMP2 expression and chronic renal allograft dysfunction in the CRAD rat model.TIMP2 表达激活 ERK1/2-NF-κB 信号通路与 CRAD 大鼠模型慢性移植肾失功的关系。
Transpl Immunol. 2024 Feb;82:101984. doi: 10.1016/j.trim.2023.101984. Epub 2024 Jan 4.
7
Inhibition of Glycogen Synthase Kinase 3β Alleviates Chronic Renal Allograft Dysfunction in Rats.抑制糖原合酶激酶 3β 可减轻大鼠慢性肾移植功能障碍。
Transplantation. 2021 Apr 1;105(4):757-767. doi: 10.1097/TP.0000000000003446.
8
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.吡非尼酮可改善梗阻后肾脏的肾功能和纤维化。
Kidney Int. 1998 Jul;54(1):99-109. doi: 10.1046/j.1523-1755.1998.00962.x.
9
Establishment of Rat Model of Insulin Resistance Exposed to Chronic Renal Allograft Dysfunction.建立慢性肾移植功能障碍大鼠胰岛素抵抗模型。
Transplant Proc. 2021 Jan-Feb;53(1):486-490. doi: 10.1016/j.transproceed.2020.06.032. Epub 2020 Aug 5.
10
Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats.吡非尼酮对5/6肾切除大鼠肾小管间质纤维化的保护作用的基础是线粒体功能的改善。
PLoS One. 2013 Dec 9;8(12):e83593. doi: 10.1371/journal.pone.0083593. eCollection 2013.

引用本文的文献

1
Pirfenidone inhibits TGF-β1-induced fibrosis via downregulation of Smad and ERK pathway in MDCK cells.吡非尼酮通过下调 MDCK 细胞中 Smad 和 ERK 通路抑制 TGF-β1 诱导的纤维化。
Vet Res Commun. 2024 Oct;48(5):3167-3176. doi: 10.1007/s11259-024-10493-y. Epub 2024 Aug 12.
2
Pirfenidone use in fibrotic diseases: What do we know so far?吡非尼酮在纤维性疾病中的应用:目前我们了解多少?
Immun Inflamm Dis. 2024 Jul;12(7):e1335. doi: 10.1002/iid3.1335.
3
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets.慢性肾脏病中的纤维化:病理生理学与治疗靶点
J Clin Med. 2024 Mar 25;13(7):1881. doi: 10.3390/jcm13071881.
4
Huangqi decoction attenuates renal interstitial fibrosis transforming growth factor-β1/mitogen-activated protein kinase signaling pathways in 5/6 nephrectomy mice.黄芪汤通过抑制转化生长因子-β1/丝裂原活化蛋白激酶信号通路减轻 5/6 肾切除小鼠的肾间质纤维化。
J Tradit Chin Med. 2022 Oct;42(5):723-731. doi: 10.19852/j.cnki.jtcm.2022.05.006.
5
Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis.聚乳酸植入物局部递送吡非尼酮可改变异物反应并预防纤维化。
Biomedicines. 2021 Jul 21;9(8):853. doi: 10.3390/biomedicines9080853.
6
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review.肺移植和慢性肺移植物功能障碍中的抗纤维化药物:综述。
Eur Respir Rev. 2021 Jun 1;30(160). doi: 10.1183/16000617.0050-2021. Print 2021 Jun 30.